Delivery Order SPE2DB22D9353-SPE2DB24FX1SS
Award Date
2/7/24
Potential Completion Date
2/8/24
Potential Value
$9.5K
Federal Agency
Defense Logistics Agency
Awardee
DMS Pharmaceutical Group Inc.
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, by the Defense Logistics Agency. The contract is a delivery order with a firm fixed price valued at $9,464.00, with a completion date of March 8, 2024. The contract is not set aside for any specific business type. DMS Pharmaceutical Group Inc. is providing the pharmaceutical product FOSAMAX 70 MG TABLET under this award. The company holds a larger indefinite delivery contract, contract 4600082013...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $4,542.72 delivery order is for the supply of Fosamax 70 mg tablets, with a performance period ending on January 23, 2024. DMS Pharmaceutical Group holds a larger indefinite delivery contract with DLA to provide a variety of pharmaceutical and medical supplies to support military treatment facilities worldwide....
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, was issued by the Defense Logistics Agency (DLA) to provide a range of pharmaceutical products. The contract, valued up to $2,284.16, is a delivery order under the DLA's SPE2DB program, which is an indefinite delivery vehicle (IDV) with a ceiling of up to $4,999,999 through 2025. Through this IDV, DMS Pharmaceutical Group will fulfill recurring medical supply needs of military health facilities, including...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $4,808.01 firm-fixed-price contract is for the delivery of Fosamax 70 mg tablets, a medication used to treat osteoporosis. The contract has an ultimate completion date of March 25, 2024 and was awarded on March 22, 2024. This appears to be a task order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA,...
This is a $6,414.52 firm fixed-price delivery order (SPE2DB22D1041|SPE2DB24FTZS4) awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc. The award is for the supply of the pharmaceutical drug Fosamax 70 mg tablets. This delivery order is part of a larger indefinite delivery contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. The IDC enables the DLA to...
This is a delivery order awarded to DMS Pharmaceutical Group Inc., a woman-owned small business, by the Defense Logistics Agency Troop Support Medical. The order is for $5,717.52 and has a firm fixed-price contract type. The order is part of a larger indefinite delivery contract, contract 4600082013 under the SPE2DB program, valued at up to $4,999,999 through the end of 2025, which enables the Defense Logistics Agency to issue delivery orders for a broad range of pharmaceutical items to...
This is a firm-fixed price delivery order for pharmaceutical products awarded to DMS Pharmaceutical Group Inc., a woman-owned small business, by the Defense Logistics Agency (DLA) under the Medical Supply Chain division. The contract award has a ceiling value of $1,627.06 and an ultimate completion date of July 15, 2024. DMS Pharmaceutical Group is the prime contractor and there is no set-aside designation mentioned. The contract provides a wide range of pharmaceutical items, including both...
This is a delivery order under contract SPE2DX24FEYKW awarded to DMS Pharmaceutical Group Inc., a woman-owned small business, by the Defense Logistics Agency to provide a variety of pharmaceutical products and medical supplies to the U.S. government. The contract has a ceiling value of $14,700.30 and runs through April 11, 2024. It is a firm-fixed-price contract without any set-aside designation. DMS Pharmaceutical Group holds an indefinite delivery contract, SPE2DB-23-D-0005, with the Defense...
This is a $34,946.55 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a for-profit woman-owned small business. The contract is for the delivery of various pharmaceutical products, including tablets, injections, creams, and biologics, to support the recurring medical supply needs of military health facilities. This delivery order is part of a larger indefinite delivery vehicle (IDV) contract, contract 4600082013 under the SPE2DB...
This firm-fixed-price delivery order contract was awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business, for the provision of a wide range of pharmaceutical products and medical supplies to the U.S. Department of Defense. The contract, valued at up to $11,840.66, has an ultimate completion date of March 14, 2024. This award is part of a larger indefinite delivery vehicle (IDV) contract, SPE2DB, held by DMS Pharmaceutical Group with the...